At day 21, immunohistochemistry indicated that positive staining with anti-α-SMA antibodies was markedly increased in lung tissue from mice treated with bleomycin (Figure 3A), whereas it was significantly reduced in PPS and PFD group. Here, ACTA1 is linked to polyostotic fibrous dysplasia.